MCM
SWAV

Manchester Capital Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Manchester Capital Management’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1
Closed -$326 – 1185
2024
Q1 		$326 Hold
1
– – ﹤0.01% 972
2023
Q4 		$191 Hold
1
– – ﹤0.01% 977
2023
Q3 		$200 Hold
1
– – ﹤0.01% 961
2023
Q2 		$286 Buy
+1
New +$278 ﹤0.01% 915

Other funds holding SWAV

SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
UWS
Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Manchester Capital Management's SWAV Position: Q2 2024 in Review

Manchester Capital Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 1 share — an estimated $326 sold.

Manchester Capital Management first reported a position in SWAV in Q2 2023 and held it in 4 quarters. The position peaked at $326 in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Manchester Capital Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Manchester Capital Management sold 1 Shockwave Medical, Inc. Common Stock share in Q2 2024, an estimated $326.
  • Manchester Capital Management first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2023 and held it in 4 quarters.
  • Manchester Capital Management's Shockwave Medical, Inc. Common Stock position peaked at $326 in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Manchester Capital Management's 13F filing for Q2 2024, filed 8 Aug 2024.